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Abstract
Rats with 6-hydroxydopamine (6-OHDA)-induced lesions of the substantia nigra are used as
a model of Parkinson’s disease (PD), and these “lesioned” rats exhibit a rotational behavior when
further injected with apomorphine (APO). We examined whether lesions in the prefrontal cortex
(PFC) could modify the rotational behavior in PD model rats. Rats initially received unilateral
lesions of the substantia nigra by 6-OHDA injection, and then their rotational behavior was mea-
sured. Two PFC lesions were achieved by intracerebral infusions of ibotenic acid, followed by
measurement of APOinduced rotation. Rotation was reduced by approximately 30&#xFF75; after
PFC injury. The PFC may have functional infl uences on the basal ganglia and may be involved in
the pathophysiology of the rotational behavior of PD model rats.
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arkinson’s disease (PD) is a neurodegenerative 
disorder mainly characterized by degeneration 
in the dopaminergic neurons of the substantia nigra 
pars compacta (SNc),  and can be modeled experimen-
tally in animals using a speciﬁ c neurotoxin for cate-
cholaminergic neurons,  such as 6-hydroxydopamine 
(6-OHDA) or 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP) [1].  The loss of nigral neurons 
produces functional modiﬁ cations that involve all 
components of the basal ganglia circuitry.  In this 
respect,  increased activity of the subthalamic nucleus 
(STN) plays a fundamental role in the pathophysiol-
ogy of PD.  Indeed,  an STN lesion has been shown 
to reduce parkinsonian symptoms in rodent [2] and 
monkey models [3] of PD.  Moreover,  high fre-
quency stimulation of the STN was found to alleviate 
parkinsonian motor symptoms in patients with dis-
abling akinetic-rigidity [4].  Patel et al. also reported 
that unilateral subthalamotomy by radiofrequency 
ablation signiﬁ cantly improved parkinsonian symp-
toms in their patients [5].  In the classic model of 
the ganglia basal network,  the enhanced activity of 
the STN neurons is thought to be the direct conse-
quence of pathological hypo-activity of the external 
segment of the globus pallidus (GP) [6].  However, 
the hyperactivity of the STN may also be explained 
by other sources of excitation or disinhibition that 
can inﬂ uence this nucleus,  such as the cerebral cor-
tex and parafascicular nucleus of the thalamus [7].
　　The cerebral cortex and the basal ganglia are 
functionally related through multi-synaptic loop cir-
cuits [8].  In rats,  the major cortical projections to 
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the STN are from the motor and pre-motor areas [9], 
which inﬂ uence the activity of the STN-GP network 
directly via excitatory projections.  However,  ana-
tomical and electrophysiological ﬁ ndings have shown 
that the STN also receives direct excitatory aﬀ er-
ents from the medial division of the prefrontal cortex 
(PFC) [9,  10].  Stimulation of the PFC has been 
shown to inﬂ uence the discharge of STN cells by the 
induction of 2 excitatory peaks,  often separated by a 
brief inhibitory peak [10].  In fact,  medial PFC and 
STN disconnection induces behavioral deﬁ cits [11], 
which suggests a reciprocal functional interaction 
between the 2 areas.  Moreover,  during eﬀ ective 
STN stimulation,  movement-related increases in 
cerebral blood ﬂ ow are higher in the supplementary 
motor area,  cingulate cortex and dorsolateral PFC, 
which may indicate the dominant role of non-primary 
motor areas in the control of movement in parkinso-
nian patients [12].  Nevertheless,  little is known 
about the inﬂ uence of the PFC on the STN in patho-
physiological conditions such as PD.
　　We hypothesized that the PFC may be related to 
the hyperactivity of the STN,  and that impairment 
of the PFC may improve behavioral abnormality in 
PD.  To test our hypothesis,  we used a well-estab-
lished rodent model of PD,  which involves unilateral 
destruction of the SNc by injection of 6-OHDA.
Materials and Methods
　　Parkinson model rat.　 Male Sprague-Dawley 
rats weighing around 250 g were housed in cages 
under controlled conditions with a constant tempera-
ture (23 ± 1 °C),  a 12-h light/dark cycle,  and ad libi-
tum access to drinking water and food.  All proce-
dures were conducted in accordance with the require-
ments of the Kagawa University Animal Committee, 
and every eﬀ ort was made to minimize both the num-
ber of animals used and their suﬀ ering.  The animals 
were deeply anaesthetized with sodium pentobarbital 
(40 mg/kg i.p.) and placed in a stereotaxic holder ﬁ t-
ted with non-traumatic ear bars.  Following local 
injection of xylocaine,  the scalp was retracted to 
expose the skull,  and craniotomies were made 
directly above the target region of the brain.  The 
drugs were injected via a stainless steel cannula 
(27-gauge) connected to a microdrive pump (model 
200 series ; KD Scientiﬁ c,  Holliston,  MA,  USA). 
Each rat received an injection of 2 ｻl of 6-OHDA 
solution (10 ｻg/ｻl) (Sigma-Aldrich,  St.  Louis,  MO, 
USA) in the right SNc (stereotaxic 
coordinates ; A ＝ 5.2 mm anterior to the bregma, 
L ＝ 2.0 mm on the right side lateral to the midline, 
V ＝ 7.8 mm below the skull).  Following the injection, 
the rat was sutured and returned to its cage.  PD 
model rats exhibit contralateral rotation upon admin-
istration of a dopamine agonist,  such as apomorphine 
(APO),  resulting from denervation supersensitivity 
[13].  To evaluate the completeness of the 6-OHDA 
lesion,  rats were tested with a subcutaneous injec-
tion of APO (0.5 mg/kg in saline solution ; Sigma-
Aldrich) 3 weeks after the 6-OHDA lesioning.  Only 
animals exhibiting at least 5 contralateral rotations/
min in 60 min were used in subsequent experiments. 
This criterion selected lesioned rats with greater 
than 95ｵ depletion of striatal dopamine and tyrosine 
hydroxylase [14].  Rotational behavior was measured 
as previously reported [15].  Brieﬂ y,  rats were 
placed in a plastic chamber and rotations were 
detected electronically using a system controlled by 
light-activated silicon-controlled rectiﬁ ers for 60 min 
after APO injection.
　　PFC lesions.　 The rats were divided into 3 
groups : an experimental group (n ＝ 7,  injection of 
ibotenic acid into the PFC),  a control-1 group (n ＝ 7, 
injection of ibotenic acid into the parietal cortex) and 
a control-2 group (n ＝ 4,  injection of saline into the 
PFC).  In the experimental group and control-2 
group,  2 ｻl of ibotenic acid solution (2.5 ｻg/ｻl) or 
saline was infused into 2 sub-areas of the right PFC 
at the following coordinates (A ＝ ＋ 3.2 mm, 
L ＝ 0.7 mm,  V ＝ 2 mm,  and AP ＝ ＋ 3.2 mm, 
L ＝ 0.7 mm,  V ＝ 5 mm),  respectively.  In the con-
trol-1 group,  4 ｻl of ibotenic acid solution was 
injected into the parietal cortex (A ＝ ＋ 2.2 mm, 
L ＝ 4.4 mm,  V ＝ 3.4 mm).  One week after PFC 
lesioning,  the rotational behavior was tested using 
the same procedure as described above.
　　Immunohistochemistry.　 All rats from the 
experimental and control groups were deeply anaes-
thetized with sodium pentobarbital (60 mg/kg i.p.) 
and perfused transcardially with 0.02 M phosphate 
buﬀ ered saline (PBS,  pH 7.4),  followed by a ﬁ xative 
of 4ｵ paraformaldehyde in PBS.  The brains were 
removed and cryoprotected in 30ｵ (w/v) sucrose at 
4 °C until they sank.  Frozen sections (20-ｻm thick-
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ness) at the SNc and striatum levels were cut coro-
nally using a freezing microtome,  mounted on glass 
slides and processed for tyrosine hydroxylase (TH) 
immunostaining (n ＝ 3 in each group).  Sections were 
incubated with TH antiserum (1/200,  polyclonal 
antibody ; Chemicon,  Temecula,  CA,  USA) over-
night at 4 °C.  This was followed by incubation for 
1 h in secondary biotinylated anti-rabbit IgG and for 
30 min with avidin-biotin complex (Vectastain,  Elite 
ABC kit ; Vector Laboratories,  Burlingame,  CA, 
USA),  followed by reaction for 3ﾝ5 min with 0.05ｵ 
diaminobenzidine-0.03ｵ hydrogen peroxidase. 
Hematoxylin and eosin staining of the PFC and SNc 
was also performed to verify the location and to 
assess the extent of lesion-induced neuronal loss.
　　Statistical analysis.　 The number of rotations 
is reported as a percentage of the pre-PFC-lesioned 
value.  Data are expressed as the mean ± s.d.  The 
statistical signiﬁ cance of diﬀ erences was assessed 
using Friedman’s χ2 r-test followed by the Wilcoxon 
t-test.  Values of p ＜ 0.05 were considered to be sta-
tistically signiﬁ cant.  For all data collection,  the 
experimenters were blinded to the group identities.
Results
　　TH staining labeled the dopamine neurons of the 
substantia nigra and ventral tegmental area (VTA) 
bilaterally in control rats,  and there was also a heav-
ily stained terminal plexus within both sides of the 
striatum (Figs.  1A,  C).  The injection of 6-OHDA 
induced a loss of TH immunoreactive cells in the 
SNc and in the associated terminal plexus in the stri-
atum on the side ipsilateral to the lesion (Figs.  1B, 
D).  PFC lesions produced by the ibotenic acid injec-
tion showed a cavity,  marked gliosis and a loss of 
neurons (Fig.  2).
　　Apomorphine induced a rotational behavior con-
tralateral to the lesion side in all Parkinson model 
rats during the session.  The rats showed progressive 
enhancement of rotational behavior following the ﬁ rst 
day’s session,  which then stabilized.  This phenome-
non may be related to the development of sensitiza-
tion induced by repeated administration of APO [15]. 
Measurements were taken over 4 consecutive days 
after rats began exhibiting stable rotational behavior. 
Following PFC-lesioning with ibotenic acid,  rota-
tional behavior signiﬁ cantly decreased (more than 30
ｵ reduction) compared with that of the pre-PFC-
lesion rats in the experimental group (Fig.  3).  On 
the other hand,  no signiﬁ cant reduction was observed 
after the lesioning of the parietal cortex in the con-
trol-1 group or saline injection into the PFC in the 
control-2 group.
Discussion
　　The present study indicated that the cortical neu-
rons in PFC could inﬂ uence the activity of the STN 
via the cortico-subthalamic pathway in 6-OHDA 
lesioned rats.  These results,  together with the simi-
lar ﬁ ndings of previous studies,  indicate that the 
PFC and STN regions are electrophysiologically 
related.  Stimulation of the PFC inﬂ uences the STN 
neurons through a direct excitatory projection [10]. 
Moreover,  the PFC may inﬂ uence the activity of 
STN cells through an indirect disinhibitory circuit 
that involves the ventral striatum,  the core of the 
nucleus accumbens,  and the ventral pallidum [10, 
17].  Stimulation of the medial prefrontal cortex has 
also been shown to induce the expression of Fos-
positive cells in the striatum and STN,  which may 
reﬂ ect the level of the aﬀ erent synaptic activity in 
the basal ganglia [18].  Interestingly,  the cortex also 
sends projections (especially from the frontal and cin-
gulate areas) to the SNc and VTA [19].  On the 
other hand,  aﬀ erents to prefrontal and cingulate cor-
tex were found to arise from the mesencephalic dopa-
minergic neurons [20].  Thus,  the cortico-subtha-
lamic pathway may represent only a part of a com-
plex network of functional interactions among the 
prefrontal cortex,  basal ganglia and nigrostriatal DA 
systems.
　　Our results demonstrate for the ﬁ rst time that 
ibotenic acid-induced lesions of the PFC can reduce 
APO-induced rotations in 6-OHDA-lesioned rats.  As 
the projections of cortical neurons have an excitatory 
eﬀ ect [21] on the STN,  these inputs may produce 
STN hyperactivity after 6-OHDA lesioning of the 
SNc.  Indeed,  blockade of the glutamatergic cortico-
STN transmission is known to suppress the early 
excitation of pallidal neurons,  whereas interference 
with the GABAergic pallido-STN neurotransmission 
has little eﬀ ect on early excitation [22].  Based on 
these ﬁ ndings,  the cortico-subthalamo-pallidal path-
way is thought to deliver powerful excitatory eﬀ ects 
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Fig. 1　　Photomicrographs showing TH immunolabeling of the 
substantia nigra pars compacta (SNc) (A,  B) and striatum (C,  D) 
of normal control (A,  C) and Parkinson model rats (B,  D).  Note 
the complete loss of TH immunolabeling within the SNc (B, 
arrows) and striatum (D,  arrowheads) of the lesioned side com-
pared with the contralateral side in the Parkinson model rats. 
Scale bars ＝ 1 mm.
Fig. 2　　Photomicrographs of the coronal section stained with 
hematoxylin and eosin showing ibotenic acid lesions in the pre-
frontal (PFC) area (arrowheads in A).  A cavity,  marked gliosis 
and a loss of neurons were observed in the PFC area of the ibo-
tenic acid injection side (B) but not in the contralateral side (C). 
Scale bars ＝ 1 mm in A and 100 ｻm in B,  C.
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from cortical areas to the pallidum [23].  Thus,  dis-
ruption of the inﬂ uence of the PFC on the STN may 
help explain our results,  through reduction of the 
excitatory signals from the cortex to the STN.
　　The present study showed that PFC lesions pro-
duced an approximately 30ｵ reduction in the number 
of rotations compared with the value before PFC 
lesioning in PD model rats.  One possible explanation 
for this ﬁ nding is that the PFC areas projecting to 
the STN may innervate only a restricted region on 
the STN [9].  Additionally,  the cortico-STN-palli-
dum pathway may not be the only source of excitation 
of the basal ganglia.  For example,  the neurons in the 
pedunculopontine nucleus and parafascicular nucleus 
of the thalamus that project to the subthalamic 
nucleus are hyperactive after nigrostriatal dopami-
nergic denervation in rats [24].  Moreover,  that fact 
that there was no reduction in rotational behavior 
following saline injection to the PFC indicates that 
some degree of destruction of the PFC is necessary 
to inﬂ uence STN activity.  Taken together,  these 
results indicate that the hyperactivity of the STN in 
Parkinson’s disease may be due not only to hypoactiv-
ity of the globus pallidus but also to strong excit-
atory inputs from other cerebral structures.
　　Our work conﬁ rms that the PFC plays a signiﬁ -
cant role in cortico-basal ganglia circuits and demon-
strates the importance of the cortico-subthalamic dis-
connection in the reduction of abnormal behavior in 
PD model rats.  Disruption of the excitatory inﬂ u-
ence of the frontal cortex on the STN may bring 
about important clinical advantages,  since it is possi-
ble to inﬂ uence the activity of the basal ganglia from 
regions of the brain more superﬁ cial than the STN. 
In this regard,  Ikeguchi et al. [25] showed that suc-
cessive repetitive transcranial magnetic stimulation 
of the frontal cortex improved parkinsonian symp-
toms.  Moreover,  high frequency electric stimulation 
of this area has been shown to result in fewer medi-
cal complications than deep lesioning or stimulation 
of the STN in Parkinson’s patients [26].  Finally, 
our ﬁ ndings reinforce the notion that mechanisms 
other than inhibitory control of the subthalamic 
nucleus by the lateral globus pallidus may underlie 
the regulation of subthalamic activity.  Further 
experiments using high frequency stimulation of the 
PFC are required to complement this study from the 
viewpoint of a potential alternative clinical treatment 
for Parkinson’s disease.
　　In conclusion,  apomorphine-induced rotational 
behavior was observed in rats having unilateral 
lesions of the substantia nigra (Parkinson model 
rats).  Additional lesions in the medial prefrontal cor-
tex signiﬁ cantly reduced the rotational behavior in 
the Parkinson model rats.  The prefrontal cortex 
might control the activity of the basal ganglia and 
play a crucial role in Parkinson’s patients.
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